Poole Jonathan bought ACAD
March 3, 2026 · Form 4 insider transaction
Poole Jonathan bought 7,482 shares of Acadia Pharmaceuticals Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 17 days after the transaction.
Direction
Acquired (buy-side)
Shares
7,482
Price
$0.00
Total value
N/A
InsiderPoole Jonathan
RoleDirector
SecurityDirector Stock Options (Right to Buy)
Transaction codeA: Grant or award
Transaction dateMarch 3, 2026
Filing dateMarch 20, 2026
Shares owned after7,482
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The shares subject to the stock option will vest in equal annual installments over three years following the date of grant such that the stock option will be fully vested on the third anniversary of the date of grant.